foxo4-dri senolytic 2023 2024 study ES2 rapidly destroys TP53-FOXO4 foci leading to TP53 mediated FOXO4-DRI - Peptide for Cellular
FOXO4 DRI Peptide for Cellular Senescence and Anti Aging Research foxo4 dri senolytic peptide human trial 2024 FOXO4 DRI UK Senolytic Peptide Research Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $5.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29



